Oct 3, 20221 min readZYNLONTA: The first and only CD19-direct ADC for 3L DLBCL ~ November 11th, 2022Full flyer info: Atalntic Fish Nov. 11th Nursing Program.pdfDownload PDF • 1.46MB
The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3
![Boston_H_color[33632]_edited.png](https://static.wixstatic.com/media/e60c5c_0b72738a80554196840094a8e387c5ed~mv2.png/v1/fill/w_338,h_77,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Boston_H_color%5B33632%5D_edited.png)
Comments